Clinical Trials Directory

Trials / Sponsors / JCR Pharmaceuticals Co., Ltd.

JCR Pharmaceuticals Co., Ltd.

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingAn Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
Mucopolysaccharidosis III-B
Phase 1 / Phase 22024-11-05
Active Not RecruitingPhase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA
Mucopolysaccharidosis III-A
Phase 1 / Phase 22023-10-04
Enrolling By InvitationAn Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subject
Mucopolysaccharidosis II
Phase 32023-02-22
Active Not RecruitingA Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
Mucopolysaccharidosis II
Phase 32022-02-14
CompletedAn Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)
Mucopolysaccharidosis I
Phase 1 / Phase 22021-10-28
CompletedA Study of JR-171 in Patients With Mucopolysaccharidosis I
Mucopolysaccharidosis I
Phase 1 / Phase 22020-09-01
Active Not RecruitingAn Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II
Mucopolysaccharidosis II
Phase 2 / Phase 32019-09-01
Active Not RecruitingAn Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
Mucopolysaccharidosis II
Phase 22019-01-01
CompletedA Study of JR-141 in Patients With Mucopolysaccharidosis II
Mucopolysaccharidosis II
Phase 2 / Phase 32018-08-01
CompletedA Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)
Mucopolysaccharidosis II
Phase 22018-07-26
CompletedA Study of JR-141 in Patients With Mucopolysaccharidosis Type II
Mucopolysaccharidosis II
Phase 1 / Phase 22017-03-30